Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz ...

Most of us don’t think twice about shampoo, deodorant, or lotion. Now, Consumer Reports reveals that some of those products ...

But the opposite is also true. A recent article in the journal Medical Humanities is a reminder that failure-based language ...

Two small-cap biotech names made serious noise today. Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% today, while Relmada Therapeutics (RLMD) sits at $7.17, also up 61.1% Both moves were ...

Although tolvaptan bests fluid restriction at raising plasma sodium concentration, 19% of patients experience overcorrection ...

The “go” decision was reached early, ahead of the company’s second quarter expected timeline. ・The results from the interim analysis appear stronger than those reported by Sanofi's experimental drug ...

In 2019, BMS made a big bet on Sotyktu by deciding to keep the then-pipeline asset despite its pending acquisition of Celgene. Based on that decision, BMS sold its mega-blockbuster Otezla to Amgen for ...

A 2026 informational consumer research report examining FocusMax cognitive support marketing claims, ingredient-level research context, proprietary blend transparency, pricing disclosures, and verific ...

Attorneys for hemp businesses say the raids have hurt their revenue and reputation, while police said they’re necessary to root out products with illegal levels of THC.

Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR rate at 12 months and 94% CR rate at any time ...

Humanitarian NGOs face criticism for politicising the term “genocide.”Oxfam, MSF, and Gift of the Givers accused of bias ...